Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

320
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
320
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

336
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
336
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

259
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
259
Regulation of Food Intake01:30

Regulation of Food Intake

3.0K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
3.0K
Causality in Epidemiology01:21

Causality in Epidemiology

1.8K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Yield and quality grade outcomes as affected by molecular breeding values for commercial beef cattle.

Journal of animal science·2015
Same author

Economic Assessment of Zoonotic Diseases: An Illustrative Study of Rift Valley Fever in the United States.

Transboundary and emerging diseases·2014
Same author

The USDA quality grades may mislead consumers.

Journal of animal science·2014
Same author

Relationships between fed cattle traits and Igenity panel scores.

Journal of animal science·2011
Same author

Association of single nucleotide polymorphisms in the leptin gene with body weight and backfat growth curve parameters for beef cattle.

Journal of animal science·2007

Related Experiment Video

Updated: Mar 9, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.4K

Economics and obesity policy.

J L Lusk1

  • 1Department of Agricultural Economics, Oklahoma State University, Stillwater, OK, USA.

International Journal of Obesity (2005)
|January 13, 2017
PubMed
Summary

Economic justifications for anti-obesity policies are often weak. Evidence suggests popular proposals like soda taxes may not significantly impact obesity rates, mirroring the issue's complexity.

Area of Science:

  • Public Health Economics
  • Obesity Policy Analysis

Background:

  • Obesity is a complex, multifaceted public health issue.
  • Numerous policy interventions aim to curb obesity rates.
  • The economic rationale for these policies requires careful examination.

Purpose of the Study:

  • To elucidate the economic challenges of popular anti-obesity policy proposals.
  • To assess the economic justifications for interventions targeting obesity.
  • To evaluate the potential impact of specific policies on obesity prevalence.

Main Methods:

  • Review of economic literature on obesity interventions.
  • Analysis of cost-effectiveness and economic impact assessments.
  • Synthesis of evidence regarding policy efficacy.

More Related Videos

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions
06:54

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions

Published on: June 21, 2019

6.4K
A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

1.4K

Related Experiment Videos

Last Updated: Mar 9, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.4K
Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions
06:54

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions

Published on: June 21, 2019

6.4K
A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

1.4K

Main Results:

  • Solid economic justifications for many anti-obesity policies are frequently absent.
  • Evidence indicates limited effectiveness of policies such as "fat taxes" or soda taxes.
  • Restrictions on food stamp spending show little promise in reducing obesity prevalence.

Conclusions:

  • The economic analysis of anti-obesity policies faces significant challenges.
  • Policy effectiveness is often overestimated, lacking robust economic backing.
  • The multifaceted nature of obesity complicates the economic evaluation of public health strategies.